Europe PMCopen access
Comparative efficacy and safety of apixaban and rivaroxaban versus warfarin in atrial fibrillation patients with end-stage renal disease: a systematic review and meta-analysis
Dialysis, Atrial fibrillation, End-stage Renal Disease, Rivaroxaban, Apixaban
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 253497
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.